Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
二十五味绿绒蒿丸 (Ershiwuwei Lvronghao Wan) is a traditional Tibetan herbal medicine manufactured by Xizang Ganlu Tibetan Medicine. It is formulated as an oral pill containing 25 ingredients, with *Meconopsis* (Lvronghao) as the principal component. In the context of Tibetan medicine, it is primarily used to clear heat, detoxify the liver, and benefit the gallbladder. It is clinically indicated for the treatment of various types of hepatitis (including chronic and viral hepatitis), cholecystitis, and liver pain. The formulation typically includes ingredients such as Meconopsis, Saffron, Bezoar, and Musk, which work synergistically to reduce inflammation and promote hepatic recovery. It is an approved pharmaceutical product in China with a National Drug License Number.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 二十五味绿绒蒿丸.